Australian molecular diagnostics developer Genetic Signatures has signed a strategic partnership with lab automation solutions provider Tecan and in vitro diagnostic software developer Repado. Announced on Tuesday, the partnership aims to create a scalable suite of fully integrated syndromic infectious disease testing systems. Financial terms were not disclosed.

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 27, 2025.

1.2 Cardiovascular Diseases (Cardiac Markers) Cardiovascular disease remains the leading cause of death worldwide. More than half a billion people around the world continue to be affected by cardiovascular disea..

Orient Gene's Respiratory Multiplex Tests Get Approved in New Zealand and Brazil Recently, some partner clients of Orient Gene have obtained registration approval from New Zealand¡¯s Medsaf..

Shares of Oxford Nanopore Technologies jumped 16 percent on Monday after the company reported strong preliminary revenues for the first half of 2025.

The University of California, Los Angeles School of Dentistry and South Korean semiconductor firm Dongwoon Anatech said on Friday that they have inked a three-year agreement worth upward of $2.4 million for the development of saliva-based liquid biopsy technologies.

One Biosciences, a French startup pursuing single-cell tumor RNA sequencing, said on Thursday that it has raised €15 million ($17.4 million) Series A financing.

President Donald Trump's proposed budget cuts to the National Institutes of Health would eventually result in fewer drugs on the market, the U.S. Congressional Budget Office said on Friday.

Fulgent Genetics announced on Thursday that it has obtained the CE-IVDR mark for its germline next-generation sequencing service.

Original from: Abbott Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2025. ¡¤ Second-quarter sales increased 7.4 percent on a reported basis, 6.9..

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced an expansion of their strategic partnership with Sanofi to enable additional U.S. drug product manufacturing. The terms of the deal were not disclosed.

To the cheers of blood centers, the US Food and Drug Administration said this week that it plans to eliminate a requirement to screen donated blood with hepatitis B virus surface antigen testing when two other testing methods are also used.

Original from: National Bureau of Statistics of China National Bureau of Statistics of China 15 July, 2025 In the first half year, under the strong leadership of the Central Committee of the ..

On 10 July 2025, the World Health Organization (WHO) prequalified the first bundled set of three in vitro rapid diagnostic tests (RDTs) capable of simultaneously detecting HIV, hepatitis B virus (HBV) and syphilis ¨C three major infections that pose serious risks to maternal and child health.

1.1 Blood Glucose The latest IDF Diabetes Atlas (2025) reports that diabetes affects 589 million adults (20-79 years) around the world in 2024, with over 4 in 10 unaware that they have the condition. Over 4 in 5..